Last year, the FDA once again set a new record for new drug approvals and far surpassed its 10-year average. Since being sworn in as FDA commissioner in 2017, Scott Gottlieb has made drug approvals a top priority for the agency. In 2018, the FDA made moves to streamline its entire drug approvals process — from early development to final application submissions. And as the country grapples with the issue of drug prices, the FDA has also found ways to significantly shorten the application process for generics and help bring more low-cost alternatives onto the market at a faster clip. Gottlieb recently said that the agency will keep up these efforts in 2019. For…Full Story
Discover recently launched or updated technologies and systems that have changed the game in pharmaceutical manufacturing.